XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.3
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of the components and classification of share-based compensation expense
The following table summarizes the components and classification of the Company’s share-based compensation expenses related to stock options and RSUs for the three and nine months ended September 30, 2025 and 2024:
Three Months Ended September 30,Nine Months Ended
September 30,
(in millions)2025202420252024
Stock options$$$12 $10 
RSUs 39 34 120 97 
$43 $38 $132 $107 
Research and development expenses$$$10 $
Selling, general and administrative expenses40 34 122 98 
$43 $38 $132 $107 
Schedule of share-based awards
Share-based awards granted for the nine months ended September 30, 2025 and 2024 consist of:
Nine Months Ended
September 30,
20252024
Bausch Health Share-Based Awards
Time-based RSUs
Granted6,277,000 5,173,000 
Weighted-average grant date fair value$7.40 $8.91 
Adjusted Operating Cash Flow performance-based RSUs
Granted2,096,000 1,332,000 
Weighted-average grant date fair value$7.36 $9.60 
Bausch + Lomb Share-Based Awards
Stock options
Granted1,374,000 1,317,000 
Weighted-average exercise price$15.86 $16.85 
Weighted-average grant date fair value$4.66 $4.92 
RSUs
Granted3,867,000 3,652,000 
Weighted-average grant date fair value$15.42 $16.77 
TSR PSUs
Granted388,000 826,000 
Weighted-average grant date fair value$15.86 $21.21 
Organic Revenue Growth PSUs
Granted753,000 379,000 
Weighted-average grant date fair value$15.98 $16.08 
OPG PSUs
Granted10,000 1,792,000 
Weighted-average grant date fair value$11.19 $17.03